A Washington man was charged in September with pointing a laser at Marine One, the presidential helicopter, while President Trump was aboard.Credit...Kenny Holston/The New York Times By Alexandra E.

Laser weapons go mobile as the US Army takes delivery of two 20-kW, anti-drone Joint Light Tactical Vehicle (JLTV)-mounted Laser-Oriented Counter-UAS System (LOCUST) Laser Weapon Systems (LWS) from ...

ABL Diagnostics Informs the Market of a Non‑Binding Letter of Intent Between ABL S.A. and ProPhase Labs (Nasdaq: PRPH) for a Proposed Reverse Merger The contemplated transaction remains subject to due ...

Asset-Based Lending: How It Works & Where To Get It Your email has been sent Asset-based lending (ABL) helps businesses borrow against receivables, inventory, real estate, and equipment. Learn how ABL ...

Energy and marine consultancy ABL has secured new five-year contracts with long-term client Woodside Energy that expands its existing workscope outside of Australia. ABL has been awarded a global ...

The engine in your car, truck, or SUV can run on either copper, platinum, or iridium spark plugs. You probably heard the hype around iridium plugs and how they manage to deliver solid sparks while ...

Eli Lilly has signed an agreement with ABL Biotech for access to the South Korean biotech's Grabody platform to develop bispecific antibodies that is worth up to $2.6B. Deal terms call for ABL Bio to ...

South Korea’s newest billionaire is Lee Sang-hoon, founder of Seoul-based ABL Bio, after it struck a $2.6 billion licensing and joint research deal with Eli Lilly for its bispecific antibody ...

ABL Bio Inc. inked a license and research agreement with Eli Lilly and Co. worth up to $2.6 billion to develop multiple therapeutics using the Grabody-B platform. Under the terms announced Nov. 12, ...

A quadcopter drone burns after being hit by a laser weapon system at Camp Roberts, California, Feb. 6, 2025. (Dan Linehan/U.S. Navy) The U.S. Army aims to produce up to 20 high-energy laser weapons to ...

Neok Bio has exited stealth with $75 million to take a pair of bispecific antibody-drug conjugates sourced from ABL Bio into the clinic. ABL, a Korean biotech that is partnered with companies ...